<DOC>
	<DOCNO>NCT02571153</DOCNO>
	<brief_summary>There evidence intraoperative administration low dos ketamine may contribute control postoperative pain act N-methyl-D-aspartate ( NMDA ) channel , reduce effect relate tolerance hyperalgesia induce opioids . This study aim evaluate effect administration agent analgesic also role quality recovery anesthesia , include observation emotional , psychological physical aspect . Patients schedule undergo total intravenous anesthesia ( TIVA ) laparoscopic cholecystectomy enrol clinical study . After induction anesthesia , patient receive one three solution accord randomly select group : ketamine 0,2 mg/kg ; ketamine 0,4 mg/kg saline . In recovery room ward , data relate presence pain , analgesic consumption , incidence nausea vomiting , dizziness hallucination record . The next day , quality recovery evaluate application questionnaire QoR40 ( Quality Recovery Questionnaire-40 ) .</brief_summary>
	<brief_title>Low Doses Ketamine Postoperative Quality Recovery</brief_title>
	<detailed_description>Introduction It know nociceptive stimulus , trigger surgery tissue inflammation cause peripheral sensitization primary hyperalgesia , increase spinal responsiveness stimulus , whether harmful , due wind-up phenomenon , mechanism , induction central sensitization . Additionally , opioids commonly employ general anesthesia may activate , , antinociceptive system pro-nociceptive system lead acute tolerance hyperalgesia . There evidence NMDA receptor involve development change low dos ketamine ( &lt; 1mg/kg ) may control postoperative pain bind receptor phencyclidine NMDA channel inhibit activation channel glutamate non-competitively . Recently , change pain management , include observation non-traditional variable relate concept satisfaction quality life relate health . To end , grow number author go assess opinion patient way determine quality recovery anesthesia , mean observation pain intensity , also aspects related emotional state , comfort independence physical . The QoR-40 questionnaire ( Quality recovery-40 ) , validate instrument purpose , allow objective approach factor influence perception patient allow compare different therapeutic way . There recent data application instrument assess effect give , , low dos ketamine quality recovery patient undergoing total intravenous anesthesia . Methods After arrival operating room , standard American Society Anesthesiologists ( ASA ) monitor apply . Midazolam 0.06 mg/kg 1 % lidocaine ( 30 mg ) administer intravenously immediately venoclysis . After anesthesia induction , capnographic monitoring add neuromuscular blockade evaluate use acceleromyography ( TOF Watch ) . Induction maintenance anesthesia perform follow : remifentanil , induction dose 0.5 μg/kg/min , follow maintenance dose 0.3 μg/kg/min . Propofol , initial bolus ( 2.0 mg/kg ) follow infusion 4 6 mg/kg/h . Each patient receive rocuronium ( 0.6 mg/kg ) tracheal intubation . Ventilation control adjust flow volume respiratory rate keep end-tidal carbon dioxid ( CO2 ) level 30 40 mmHg . In case inadequate depth anesthesia ( movement , sweating , tachycardia , blood pressure increase &gt; 10 % pre-induction value ) , propofol infusion sevoflurane rate increase ( 1 % ) ; sufficient , remifentanil infusion rate also increase ( 0,1 μg/kg/min ) . Patients exhibit reduction systolic arterial pressure ( SAP ) great 30 % heart rate ( HR ) reduction less 50 bpm give ephedrine ( 10 mg ) atropine ( 0.5 mg ) , respectively . After induction patient receive one three intravenous solution : ketamine 0.2 mg/kg - dilute saline volume 5 mililiters ( mL ) ( k2 group ) ; ketamine 0.4 mg/kg dilute saline volume 5 ml ( k4 group ) 5mL 0.9 % normal saline ( K0 group ) . Hydration maintain 0.9 % normal saline 2 ml/kg/h . All participant give dexamethasone ( 8 mg ) ketoprofen ( 100 mg ) onset surgery dimenhydrinate ( 30 mg ) , dipyrone ( 1 g ) morphine ( 0.1 mg/kg ) 15 minute prior end procedure . Atropine ( 0.01 mg/kg ) neostigmine ( 0.05 mg/kg ) use achieve T4/T1 &gt; 0.9 TOF monitor . Extubation perform awaken . When stable vital sign respiration confirm , patient transfer postanesthesia care unit ( PACU ) . Data relate occurrence pain , nausea , vomit , dizziness hallucination PACU record length stay PACU . Pain assess every 15 minute use 0-10 numeric pain rating scale , zero meant pain 10 bad imaginable pain . Morphine ( 1 2 mg ) administer intravenously every 10 minute maintain pain score 4 ( 1 mg pain score &lt; 7 2 mg ≥7 ) . Following discharge PACU ( minimum stay 60 minute Aldrete &amp; Kroulik index &gt; 9 ) , participant give ketoprofen ( 100 mg ) every 12 hour dipyrone ( 30 mg/kg , maximum 1 g ) every six hour intravenously . Whenever patient judge analgesia insufficient , tramadol ( 100 mg ) administer intravenously eight-hour minimum interval need . Postoperative nausea vomiting ( PONV ) treat dimenhydrinate ( 30 mg ) intravenously . Pain score , use analgesic , occurrence nausea , vomit , complication hospital ward stay record . QoR40 The quality postoperative functional recovery assess QoR40 questionnaire , assess five dimension recovery ( physical comfort - 12 item ; emotional state - 7 item ; physical independence - 5 item ; physiological support - 7 item ; pain - 7 item ) . Each item rat five-point Likert scale : none time , time , usually , time , time . The total score QoR40 range 40 ( poor quality recovery ) 200 ( best quality recovery ) . The QoR40 administer blind investigator 24 hour surgery .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>American Society Anesthesiologists physical status I II Patients schedule undergo laparoscopic cholecystectomy Patients refuse participate study Patients able communicate due alteration level consciousness , neurologic , psychiatric disease Contraindication drug use study Patients superobese ( BMI &gt; 40 ) History alcohol drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Intravenous anesthesia</keyword>
	<keyword>Postoperative nausea vomit</keyword>
	<keyword>Postoperative pain</keyword>
	<keyword>Patient satisfaction</keyword>
	<keyword>Quality health care</keyword>
	<keyword>Ketamine</keyword>
</DOC>